InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.
InStride Health has raised $30.0M in total funding. The most recent round was Series C. The last funding was announced in June 2026.
InStride Health's investors include General Catalyst, .406 Ventures, FMZ Ventures, Hopelab, Echo Health Ventures.
InStride Health is headquartered in Boston, United States.
InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.
InStride Health is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InStride Health — Funding & Investors." VCBacked, June 15, 2026, https://www.vcbacked.co/company/instride-health. Accessed September 14, 2026.
VCBacked. (2026). InStride Health — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/instride-health
{{cite web |title=InStride Health — Funding & Investors |url=https://www.vcbacked.co/company/instride-health |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated